Clinical Trial Update: Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and adherence of a dapivirine vaginal ring for HIV prevention has completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dapivirine vaginal ring (dapivirine)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: Human Immunodeficiency Virus | Phase 3 | Status: COMPLETED | Results posted: 2022-10-25